Should the FDA speed up or slow down approval of new cancer drugs?

Should the FDA speed up or slow down approval of new cancer drugs?

Opinion: Should the FDA speed up or slow down approval of new cancer drugs?

By JASON SHAFRIN

CARLOS OSORIO/AP

While increased evidence requirements may improve health outcomes, it's important to consider that the delays they cause may cost lives.

READ MORE